Nanoparticles
How DIANT Pharma is Transforming Nanoparticle Manufacturing
Antonio Costa, Ph.D.
DIANT Pharma
PAO-04-24-PHEX-26Jul 02, 2025
Nanoscale
Addressing Drug Delivery Challenges at the Nanoscale
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-25-NI-07Jun 16, 2025
Lipid Nanoparticles
Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing
Jim Ziogas
DIANT Pharma
PAO-05-24-CL-03May 30, 2024
mRNA Innovations
Technology Advances Needed to Drive Future mRNA Growth
Hagen Richter, Ph.D.
Wacker
PAO-04-24-CL-04Apr 15, 2024
mRNA–LNP Manufacturing
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-03-24-CL-08Mar 18, 2024
Lipid Nanoparticles
Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform
Antonio Costa, Ph.D.
DIANT Pharma
PAO-10-23-CL-03Nov 01, 2023
New Integrated mRNA Offering
Building on Experience and Investing in an Integrated mRNA Offering
Jessica Madigan; Normand Blais
BIOVECTRA
PAO-07-23-CL-03Jul 31, 2023
Continuous Processing
US Food and Drug Administration (FDA) Purchase the LiFT System from DIANT® Pharma INC.
DIANT Pharma
PR-M07-23-03Jul 31, 2023
Lipid Nanoparticles
Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-04-23-CL-05May 06, 2023
Lipid Nanoparticles
Lipid Nanoparticles: Transforming the Nanomedicines Market
Antonio Costa, Ph.D.
DIANT Pharma
PAO-02-23-CL-01Feb 07, 2023
Lipid Nanoparticle Development
Lipid Technology for Delivery of Gene-Editing Therapies
Stephen Burgess, Ph.D.
Croda Pharma
PAO-11-022-CL-18Jan 17, 2023
Quality by Design
A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies
Lynda Menard, Ph.D.; Grant Henderson, Ph.D.
Vernal Biosciences
PAO-11-022-CL-06Jan 10, 2023
Custom Lipid Nanoparticle Development
The Value of a Custom Lipid Solutions Provider for mRNA Delivery
Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.
Evonik
PAO-11-022-CL-17Jan 05, 2023
Quality in mRNA Manufacturing
Quality in Equals Quality Out in mRNA Manufacturing
Judith McCorry
Vernal Biosciences
PAO-10-022-CL-08Nov 08, 2022
mRNA Manufacture
Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers
Tonia Becker
Nice Insight
PAO-10-022-CL-03Oct 25, 2022
Lipid Excipients
Regulatory Considerations for Lipid Excipients
Claudia Widmann; Estelle Beguin Ph.D.
MilliporeSigma
PAO-07-022-CL-04Aug 15, 2022
Lipid Nanoparticles
Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing
Cole Byvelds, P.Eng.; Kristina Parrant
Evonik
PA656Dec 14, 2021
mRNA
Integrated Support Facilitates mRNA Product Development and Commercialization
Michael Wourms; Dave Stevens
Arranta Bio
PAO-10-21-CL-15Oct 26, 2021
Lipid Nanoparticles
Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing
Natalia Zisman
Evonik
PAO-07-21-CL-02Jul 12, 2021
mRNA Therapies
Realizing the Promise of RNA Therapies with Lipid Nanoparticle Delivery
Shiksha Mantri, Ph.D.
MilliporeSigma
PAO-06-21-CL-08Jun 16, 2021